1. Home >
  2. M&A >
  3. Stake Purchase >
  4. United States >
  5. Georgia >
  6. PharmaCyte Biotech Invests In Femasys

Investment Summary

PharmaCyte Biotech Invests In Femasys

On November 15, 2023, PharmaCyte Biotech invested in life science company Femasys

Investment Highlights
  • This is PharmaCyte Biotech’s 1st transaction in the Life Science sector.
  • This is PharmaCyte Biotech’s 1st transaction in the United States.
  • This is PharmaCyte Biotech’s 1st transaction in Georgia.

Investment Summary
Date 2023-11-15
Target Femasys
Sector Life Science
Investor(s) PharmaCyte Biotech
Deal Type Stake Purchase

Target

Femasys

Suwanee, Georgia, United States
Femasys a biomedical company focused on meeting significant unmet needs for women worldwide. Femasys offers a broad portfolio of in-office, accessible solutions, including a lead late-stage product candidate and innovative therapeutic and diagnostic products. Femasys is based in Suwanee, Georgia.

Search 205,905 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

PharmaCyte Biotech

Las Vegas, Nevada, United States
Category Company
Sector Life Science
Employees2
Revenue 6M USD (2024)
DESCRIPTION

PharmaCyte Biotech is a biotechnology company focused on evaluating its signature live-cell encapsulation technology, Cell-in-a-Box, for potential development of cellular therapies for cancer, diabetes and malignant ascites. PharmaCyte Biotech was founded in 1996 and is based in Las Vegas, Nevada.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Stake Purchase) 1 of 1
State (Georgia) 1 of 1
Country (United States) 1 of 1
Year (2023) 1 of 1
Mergr

Product

Company

Legal